Upgrade to SI Premium - Free Trial

Form 3 NICE Ltd. For: Mar 18 Filed by: Neder Shiri

March 18, 2026 9:20 AM
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Neder Shiri
(Last) (First) (Middle)
221 RIVER STREET
(Street)
HOBOKEN NJ 07030
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026 		3. Issuer Name and Ticker or Trading Symbol
NICE Ltd. [ NICE ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Human Resources
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options (1) 03/03/2027 Ordinary Shares 1,800 0.307 D
Options (1) 02/16/2028 Ordinary Shares 3,750 0.3142 D
Options (1) 03/03/2028 Ordinary Shares 1,200 0.307 D
Options (1) 02/16/2029 Ordinary Shares 2,500 0.3142 D
Options (2) 02/22/2029 Ordinary Shares 9,150 0.273 D
Options (3) 02/21/2030 Ordinary Shares 9,150 0.2718 D
Options (4) 02/22/2030 Ordinary Shares 6,100 0.273 D
Options (5) 06/01/2030 Ordinary Shares 4,800 0.2706 D
Options (6) 02/21/2031 Ordinary Shares 6,100 0.2718 D
Options (7) 02/19/2031 Ordinary Shares 10,000 0.2824 D
Options (8) 06/01/2031 Ordinary Shares 3,200 0.2706 D
Options (9) 02/18/2032 Ordinary Shares 12,500 0.3228 D
Options (10) 02/19/2032 Ordinary Shares 10,000 0.2824 D
Options (11) 02/18/2033 Ordinary Shares 10,000 0.3228 D
Explanation of Responses:
1. The stock option is fully vested and currently exercisable.
2. The stock option is vested and exercisable with respect to 6,862 Ordinary Shares and will vest with respect to the remaining shares on February 22, 2027.
3. The stock option is vested and exercisable with respect to 4,575 Ordinary Shares and will vest with respect to the remaining shares in substantially equal installments on February 21, 2027 and February 21, 2028.
4. The stock option is vested and exercisable with respect to 4,575 Ordinary Shares and will vest with respect to the remaining shares on February 22, 2027.
5. The stock option is vested and exercisable with respect to 2,400 Ordinary Shares and will vest with respect to the remaining shares on June 1, 2027.
6. The stock option is vested and exercisable with respect to 3,050 Ordinary Shares and will vest with respect to the remaining shares in substantially equal installments on February 21, 2027 and February 21, 2028.
7. The stock option is vested and exercisable with respect to 2,500 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on February 19, 2027, February 19, 2028 and February 19, 2029.
8. The stock option is vested and exercisable with respect to 1,600 Ordinary Shares and will vest with respect to the remaining shares on June 1, 2027.
9. The stock option will vest in substantially equal installments on February 18, 2027, February 18, 2028, February 18, 2029 and February 18, 2030.
10. The stock option is vested and exercisable with respect to 2,500 Ordinary Shares and will vest with respect to the remaining shares in substantially equal installments on February 19, 2027, February 19, 2028 and February 19, 2029
11. Each Option represents a contingent right to receive one Ordinary Share of the Issuer. The Options are eligible to vest over a three-year performance period ending February 18, 2029, subject to adjustments in accordance with the terms of the awards, based upon the Issuer?s achievement of specified stock price performance thresholds.
Remarks:
Exhibit 24 - Power of Attorney.
/s/ Alon Levy, Attorney-in-Fact for Shiri Neder 03/18/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

ATTACHMENTS / EXHIBITS

EXHIBIT 24.1

Categories

SEC Filings